Target intelligence / Profile preview

Insulin receptor-related receptor (INSRR) (INSRR)

Target
INSRR
Molecular classification
Receptor tyrosine kinase, Insulin receptor family, Enzyme, Receptor
01

Overview

The Insulin receptor-related receptor (INSRR) is a member of the insulin receptor subfamily of receptor tyrosine kinases, which also includes the insulin receptor (INSR) and the insulin-like growth factor 1 receptor (IGF1R) (UniProt P14616). Unlike its homologs, INSRR is an orphan receptor that is not activated by insulin or insulin-like growth factors; instead, it functions as a specific cell surface alkali sensor (Deyev et al., 2011, PMID: 21633350). It is primarily expressed in the intercalated cells of the kidney's collecting ducts, where it responds to extracellular alkaline environments by undergoing autophosphorylation and triggering signaling pathways that promote bicarbonate excretion (Petrenko et al., 2013, PMID: 23836911). This unique physiological role makes INSRR a critical regulator of systemic acid-base homeostasis. While it is not currently a primary target for approved therapeutics, its role in renal pH regulation suggests potential relevance in metabolic alkalosis and certain kidney disorders. Research into small molecule modulators of INSRR is ongoing to explore its potential in managing conditions characterized by acid-base imbalances (Popova et al., 2019, PMID: 31463306).

Other names
IRRInsulin receptor-related proteinProtein tyrosine kinase receptor INSRRIR-related receptor
02

Mechanism of action

Activation by extracellular alkaline pH (typically >7.9) induces conformational changes and autophosphorylation of the intracellular kinase domain, which subsequently activates the PI3K/Akt and MAPK/ERK signaling pathways to facilitate renal bicarbonate secretion (Deyev et al., 2011, PMID: 21633350; Petrenko et al., 2013, PMID: 23836911).

03

Biological functions

Signal transductionAcid-base homeostasisProtein phosphorylationBicarbonate excretionAlkali sensing
04

Disease associations

Metabolic alkalosisKidney diseaseOther
05

Safety considerations

Risk of metabolic acidosis if over-inhibitedPotential off-target inhibition of Insulin Receptor (INSR) or IGF-1 Receptor (IGF1R)Disruption of renal electrolyte handling
06

Biomarkers

Urinary pHSerum bicarbonate levelsINSRR expression in renal intercalated cells

Beyond the preview

Go deeper on Insulin receptor-related receptor (INSRR) (INSRR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Insulin receptor-related receptor (INSRR) (INSRR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call